Low concentration of BDNF in the acute phase of ischemic stroke as a factor in poor prognosis in terms of functional status of patients

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 3900-3905

  Lasek Bal, Anetta ^a,b   Jędrzejowska Szypułka, Halina ^b   Różycka, Jagoda ^a   Bal, Wiesław ^c   Holecki, Michał ^a   Duława, Jan ^a   Lewin Kowalik, Joanna ^b  

^a Upper Silesian Heart Center Katowice   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Brain derived neurotrophic factor; Prognosis; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; CLOPIDOGREL; HEPARIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; BLOOD CLOT LYSIS; BLOOD SAMPLING; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE ASSESSMENT; DYSLIPIDEMIA; FEMALE; FUNCTIONAL STATUS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MRANKIN SCALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PROGNOSIS; PROSPECTIVE STUDY; THROMBECTOMY; VERY ELDERLY; ACUTE DISEASE; BLOOD; CEREBROVASCULAR ACCIDENT; MIDDLE AGED; PATHOPHYSIOLOGY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOMARKERS; BRAIN ISCHEMIA; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; STROKE;

EID: 84949871119     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.895358     Document Type: Article

References (29)

1. Hohlfeld R: Neurotrophic cross-talk between the nervous and immune systems: Relevance for repair strategies in multiple sclerosis? J Neurol Sci, 2008; 265: 93–96
2. Huang EJ, Reichardt LF: Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci, 2001; 24: 677–736
3. Kaplan DR, Miller FD: Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol, 2000; 10: 381–91
4. Ho VM, Lee JA, Martin KC: The cell biology of synaptic plasticity. Science, 2011; 334: 623–28
5. Linker RA, Gold R, Lühder F: Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination. Crit Rev Immunol, 2009; 29: 43–68
6. Tsai YW, Yang YR, Sun SH et al: Post-ischemia intermittent hypoxia induces hippocampal neurogenesis and synaptic alterations and alleviates longterm memory impairment. J Cereb Blood Flow Metab, 2013; 33: 764–73
7. Gorelick PB, Scuteri A, Black SE et al: Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2011; 42: 2672–713
8. Pikula A, Beiser A, Chen T et al: Serum BDNF and VEGF levels are associated with Risk of Stroke and Vascular Brain Injury: Framingham Study. Stroke, 2013; 44(10): 2768–75
9. The World Bank. World Development Report 1993. Investing in health. Oxford University Press, Oxford, 1993
10. Amarenco P, Bogousslavsky J, Caplan LR et al: The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping). Cerebrovasc Dis, 2013; 36: 1–5
11. Young FB, Weir CJ, Lees KR: GAIN International Trial Steering Committee and Investigators. Comparison of the National Institutes of Health Stroke Scale with disability outcome measures in acute stroke trials. Stroke, 2005; 36: 2187–92
12. Weisscher N, Vermeulen M, Roos YB, de Haan RJ: What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2? J Neurol, 2008; 255: 867–74
13. Mancia G, De Backer G, Dominiczak A et al: Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J, 2007; 28: 1462–536
14. American Diabetes Association: Standards of medical care in diabetes – 2013. Diabetes Care, 2013; 36: 11–66
15. North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med, 1991; 325: 445–53
16. Zhao J, Wu H, Zheng L et al: Brain-derived neurotrophic factor G196A polymorphism predicts 90-day outcome of ischemic stroke in Chinese: a novel finding. Brain Res, 2013; 1537: 312–18
17. Golden E, Emiliano A, Maudsley S et al: Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: Data from the Baltimore longitudinal study of aging. PLoS One, 2010;5: e10099
18. Ferris LT, Williams JS, Shen CL: The effect of acute exercise on serum brainderived neurotrophic factor levels and cognitive function. Med Sci Sports Exerc, 2007; 39: 728–34
19. Celik-Guzel E, Bakkal E, Guzel S et al: Can low brain-derived neurotrophic factor levels be a marker of the presence of depression in obese women? Neuropsychiatr Dis Treat, 2014; 10: 2079–86
20. Kleim JA, Jones TA, Schallert T: Motor enrichment and the induction of plasticity before or after brain injury. Neurochem Res, 2003; 28: 1757–69
21. Schabitz WR, Steigleder T, Cooper-Kuhn CM et al: Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke, 2007; 38: 2165–72
22. Alonso M, Medina JH, Pozzo-Miller L: ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. Learn Mem, 2004; 11: 172–78
23. Pizarro JM, Lumley LA, Medina W et al: Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice. Brain Res, 2004; 1025: 10–20
24. Zhao Y, Xiao M, He W, Cai Z: Minocycline upregulates cyclic AMP response element binding protein and brain-derived neurotrophic factor in the hippocampus of cerebral ischemia rats and improves behavioral deficits. Neuropsychiatric Dis Treat, 2015; 11: 507–16
25. Debette S, Markus HS: The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: Systematic review and metaanalysis. BMJ, 2010; 341: c3666
26. Jeerakathil T, Wolf PA, Beiser A et al: Stroke risk profile predicts white matter hyperintensity volume: The Framingham Study. Stroke, 2004; 35: 1857–61
27. Au R, Massaro JM, Wolf PA et al: Association of white matter hyperintensity volume with decreased cognitive functioning: The Framingham Heart Study. Arch Neurol, 2006; 63: 246–50
28. Santhanam AV, Smith LA, Katusic ZS: Brain-derived neurotrophic factor stimulates production of prostacyclin in cerebral arteries. Stroke, 2010; 41: 350–56
29. Xu SY, Pan SY: The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy. Med Sci Monit Basic Res, 2013; 19: 37–45